Cargando…

Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells

Acute myeloid leukemia (AML) cells harbor elevated levels of reactive oxygen species (ROS), which promote cell proliferation and cause oxidative stress. Therefore, the inhibition of ROS formation or elevation beyond a toxic level have been considered as therapeutic strategies. ROS elevation has rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demircan, Muhammed Burak, Mgbecheta, Peter C., Kresinsky, Anne, Schnoeder, Tina M., Schröder, Katrin, Heidel, Florian H., Böhmer, Frank D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944474/ https://www.ncbi.nlm.nih.gov/pubmed/35326163 http://dx.doi.org/10.3390/antiox11030513

Ejemplares similares

Setanaxib (GKT137831) Ameliorates Doxorubicin-Induced Cardiotoxicity by Inhibiting the NOX1/NOX4/Reactive Oxygen Species/MAPK Pathway
por: Zheng, Hui, et al.
Publicado: (2022)

Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)
por: Demircan, Muhammed Burak, et al.
Publicado: (2022)

Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina
por: Deliyanti, Devy, et al.
Publicado: (2015)

Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan
por: De Livera, Alysha M., et al.
Publicado: (2020)

Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
por: Zeng, Si-yu, et al.
Publicado: (2020)

Effects of the combination of P3-based GKT and reality monitoring on deceptive classification
por: Jang, Ki-Won, et al.
Publicado: (2013)

A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNs
por: Schnoeder, Tina M., et al.
Publicado: (2021)

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial
por: Jones, David, et al.
Publicado: (2023)

Pre‐clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis
por: Thannickal, Victor J., et al.
Publicado: (2023)

Antifungal mechanism of Bacillus amyloliquefaciens strain GKT04 against Fusarium wilt revealed using genomic and transcriptomic analyses
por: Tian, Dandan, et al.
Publicado: (2021)

Synergistic killing of FLT3ITD-positive AML cells by combined inhibition of tyrosine-kinase activity and N-glycosylation
por: Tsitsipatis, Dimitrios, et al.
Publicado: (2017)

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells
por: Drube, Julia, et al.
Publicado: (2018)

Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literature
por: Wolleschak, Denise, et al.
Publicado: (2013)

Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia
por: Eifert, Theresa, et al.
Publicado: (2023)

The Genomic Landscape of Myeloid Malignancies: Options for Pan-myeloid Therapies?
por: Heidel, Florian H., et al.
Publicado: (2021)

Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia
por: Straube, Jasmin, et al.
Publicado: (2023)

Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification
por: Tian, Tian, et al.
Publicado: (2019)

JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1
por: Gupta, N, et al.
Publicado: (2017)

Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies
por: Ernst, Philipp, et al.
Publicado: (2021)

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression
por: Arora, Deepika, et al.
Publicado: (2012)

The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells
por: Bhat, Purnima, et al.
Publicado: (2014)

Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties
por: Kawakami, Koji, et al.
Publicado: (2006)

Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein
por: Luangwattananun, Piriya, et al.
Publicado: (2022)

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity
por: Halle, Stephan, et al.
Publicado: (2016)

Redox Regulation Beyond ROS: Why ROS Should Not Be Measured as Often
por: Brandes, Ralf P., et al.
Publicado: (2018)

Targeting Cdk5 for killing of breast cancer cells via perturbation of redox homeostasis
por: NavaneethaKrishnan, Saranya, et al.
Publicado: (2018)

Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing
por: Marreddy, Ravi K. R., et al.
Publicado: (2021)

Protection of Hepatocytes from Cytotoxic T Cell Mediated Killing by Interferon-Alpha
por: Willberg, Christian B., et al.
Publicado: (2007)

Cyclooxygenase 2 Modulates Killing of Cytotoxic T Lymphocytes by Colon Cancer Cells
por: Wang, Quanxin, et al.
Publicado: (2009)

Correction: The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells
Publicado: (2014)

Less cholesterol means better tumor killing for cytotoxic T9 cells
por: Griesenauer, Brad, et al.
Publicado: (2018)

Supramolecular attack particle: the way cytotoxic T lymphocytes kill target cells
por: Liu, Jiaqi, et al.
Publicado: (2020)

Cx43-Gap Junctions Accumulate at the Cytotoxic Immunological Synapse Enabling Cytotoxic T Lymphocyte Melanoma Cell Killing
por: Hofmann, Francisca, et al.
Publicado: (2019)

A novel association between TGFβl and ADAMTS4 in coronary artery disease: A new potential mechanism in the progression of atherosclerosis and diabetes
por: Uluçay, Safiye, et al.
Publicado: (2015)

Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2017)

Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo
por: Asquith, Becca, et al.
Publicado: (2006)

Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes
Publicado: (1992)

Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes
por: Bassoy, Esen Yonca, et al.
Publicado: (2016)

Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART
por: Denton, Paul W., et al.
Publicado: (2014)

Tissue Dimensionality Influences the Functional Response of Cytotoxic T Lymphocyte-Mediated Killing of Targets
por: Gadhamsetty, Saikrishna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v4vmljs9b2if219lrpvnvgn5uc